Xylo is a startup based in unknown, most recent round Seed, 2 tracked investors.
Based in unknown, Xylo is a startup. Its most recent tracked round is Seed. Brouky records 2 investors associated with the company.
Xylo develops targeted neurotherapeutics designed to enhance neuroplasticity and restore brain function for neurological and psychiatric disorders using advanced neuroscience and computational drug discovery.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.